Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging pathogens.

J Pontón1, R Rüchel, K V Clemons

  • 1Departamento de Inmunología, Microbiología y Parasitología, Universidad del País Vasco, Bilbao, Spain. oipposaj@lg.ehu.es

Medical Mycology
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2016
Same author

Prospective Evaluation of a New Aspergillus IgG Enzyme Immunoassay Kit for Diagnosis of Chronic and Allergic Pulmonary Aspergillosis.

Journal of clinical microbiology·2016
Same author

Resilience and related factors in urban, mid-aged Spanish women.

Climacteric : the journal of the International Menopause Society·2015
Same author

Combination antifungal therapy: a strategy for the management of invasive fungal infections.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2014
Same author

Sertaconazole antifungal profile determined by a microdilution method versus nine topical substances against dermatophyte fungi.

Chemotherapy·2013
Same author

Biofilm formation by five species of Candida on three clinical materials.

Journal of microbiological methods·2011
Same journal

Diagnostic performance of IgG against multiplex Aspergillus antigens (mx4) for identifying chronic pulmonary aspergillosis.

Medical mycology·2026
Same journal

The clinical utility of bronchoalveolar lavage galactomannan result stewardship within a tertiary medical system.

Medical mycology·2026
Same journal

Cross-reactivity of Cryptococcal Antigen Lateral Flow Assay with Basidiomycetous Yeasts.

Medical mycology·2026
Same journal

Cryptococcus gattii complex infections in southern Brazil: epidemiology, clinical features, management and outcomes from a 33-year cohort.

Medical mycology·2026
Same journal

HAC1 contributes to stress adaptation and virulence in the emerging fungal pathogen Candida auris.

Medical mycology·2026
Same journal

Multicenter Study Reveals Alarming Terbinafine Resistance in Trichophyton indotineae Isolates from Iran.

Medical mycology·2026
See all related articles

Emerging fungal pathogens like Candida dubliniensis and Saccharomyces cerevisiae are causing opportunistic infections in immunosuppressed individuals. Further research is needed to understand and control these newly recognized human fungal pathogens.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Increasing numbers of immunosuppressed individuals lead to a rise in opportunistic fungal infections.
  • Common fungal pathogens are well-documented, but new species are emerging as human pathogens.
  • Previously unrecognized or non-pathogenic fungi like Candida dubliniensis, Saccharomyces cerevisiae, Scedosporium spp., and Fusarium spp. are causing disease.

Purpose of the Study:

  • To describe the emergence of specific yeast (Candida dubliniensis, Saccharomyces cerevisiae) and mould (Scedosporium prolificans, Fusarium spp.) species as human pathogens.
  • To highlight the poor understanding of the role of these emerging pathogens in human disease.
  • To underscore the challenges in identifying these species and their inadequate response to conventional antifungal therapies.

Related Experiment Videos

Main Methods:

  • Review of emerging fungal pathogens.
  • Description of yeast and mould species causing human disease.
  • Discussion of identification challenges and treatment failures.

Main Results:

  • Candida dubliniensis and Saccharomyces cerevisiae identified as emerging yeast pathogens.
  • Scedosporium prolificans and Fusarium spp. identified as emerging mould pathogens.
  • Challenges in species identification and epidemiology of these emerging pathogens noted.

Conclusions:

  • Emerging fungal pathogens pose a growing threat to immunosuppressed populations.
  • Further research is crucial to understand the pathogenesis and epidemiology of these fungi.
  • Development of effective diagnostic and therapeutic strategies is urgently needed to control these infections.